Using this array of genes, Mercola created a biomarker test for prostate cancer that renders a prognosis at the same time as diagnosis. Knowing whether they have the aggressive or indolent version, he says, lets patients better understand their disease and treatment options. To test this method,...
Eosinophilia was seen in 26 of 293 patients with fibromyalgia (8.9%), 3 of 182 patients with rheumatoid arthritis (1.65%), and none of 12 patients with scleroderma, but the low prevalence might be explained by the frequent use of corticosteroids among these patients [99]. A recent study ...